Nicholas F. Dybdal‐Hargreaves

Statistics

Publications

Citations

884

H-Index

Active since

2011

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Audie L. Murphy Memorial VA Hospital

New Mexico Institute of Mining and Technology

Universidade Federal de Santa Catarina

Université Libre de Bruxelles

Nicholas F. Dybdal‐Hargreaves is an author at The University of Texas at San Antonio Health Science Center specializing in medicine, oncology, and microtubule-targeting agents.

ORCID

Publications per year

2011–2017

Publications

Effect of Irrigants on the Survival of Human Stem Cells of the Apical Papilla in a Platelet-rich Plasma Scaffold in Human Root Tips

Ernesto G. Trevino, Amol N. Patwardhan, Michael Henry et al. · Journal of Endodontics · 2011 · 377 citations

Dentistry, Bioengineering, Periodontics +16

Molecular Recognition of Insulin by a Synthetic Receptor

Jordan M. Chinai, Alexander B. Taylor, Lisa M. Ryno et al. · Journal of the American Chemical Society · 2011 · 318 citations

Life Sciences, Biochemistry, Molecular Biology +17

The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents

Xin Zhang, Sudhir Raghavan, Michael A. Ihnat et al. · Bioorganic & Medicinal Chemistry · 2014 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

Breast Cancer Cell Lines Exhibit Differential Sensitivities to Microtubule-targeting Drugs Independent of Doubling Time.

April L. Risinger, Nicholas F. Dybdal‐Hargreaves, Susan L. Mooberry · PubMed · 2015 · 31 citations

Medicine, Cell Biology, Oncology +14

Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas/Src inhibition by eribulin

Nicholas F. Dybdal‐Hargreaves, April L. Risinger, Susan L. Mooberry · Oncotarget · 2017 · 28 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 9